Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: a case-control study
American Journal of Epidemiology · 05.08.2025 · 194 (8) · 2287-2294
DOI: 10.1093/aje/kwae368 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift American Journal of Epidemiology, online erschienen am 20.09.2024. Verfasst von L Hannah Gould und 11 weiteren Autor:innen. Beteiligte Einrichtung: Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, NY, United States. Hauptthemen laut MEDLINE: Lyme Disease, Rural Population, Urban Population, Suburban Population. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer Inc and Valneva.
Abstract (Originalsprache)
Lyme disease (LD) is the most common vector-borne disease in the United States, with 476 000 cases estimated each year. It is unclear how LD risk factors vary by residential setting. We conducted a case-control study on LD risk according to rural, urban, and suburban residential settings. Individuals from 15 high-incidence states and the District of Columbia in the Optum Research Database were identified as cases (LD medical claim) or controls (no LD medical claim, matched by county of residence and census block group population density). Participants were surveyed about LD history, outdoor activities, and residential characteristics. The final analytic data set had 750 LD cases and 965 controls. Residence in a rural setting had increased LD risk (odds ratio [OR], 1.41; 95% CI, 1.16-1.72). In multivariable analyses, activities associated with LD were hiking/walking/running or having an occupation in forests, wooded areas, or areas of tall grass (all respondents), and spending time in a yard (rural and urban residents only). Public health interventions can help prevent LD in high-incidence jurisdictions by reinforcing the near-universal LD risk for rural residents and highlighting activities that lead to increased LD risk for those in areas with less ubiquitous tick exposure like in urban and suburban settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, NY, United States.
- Optum, Eden Prairie, MN, United States.
- Medical Affairs, Evidence Generation Statistics, Pfizer Inc, Cambridge, MA, United States.
- Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Paris, France.
- Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Cambridge, MA, United States.
ORCID-Profile: L Hannah Gould, Rebecca Fee, Noah Webb, Maureen Carlyle, Frederick J Angulo, James H Stark, Sarah Pugh
Förderung
- Pfizer Inc and Valneva
Zitieren
APA
Gould, L. H., Fee, R., White, J., Webb, N., Carlyle, M., Dick, L., Tan, Y., Walker, V., Angulo, F. J., Moïsi, J. C., Stark, J. H., & Pugh, S. (2025). Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: a case-control study. American Journal of Epidemiology, 194(8), 2287-2294. https://doi.org/10.1093/aje/kwae368
Vancouver
Gould LH, Fee R, White J, Webb N, Carlyle M, Dick L, et al. Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: a case-control study. American Journal of Epidemiology. 2025;194(8):2287-2294. doi:10.1093/aje/kwae368
BibTeX
@article{Gould2025,
author = {Gould, L Hannah and Fee, Rebecca and White, John and Webb, Noah and Carlyle, Maureen and Dick, Laura and Tan, Ye and Walker, Valery and Angulo, Frederick J and Moïsi, Jennifer C and Stark, James H and Pugh, Sarah},
title = {Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: a case-control study},
journal = {American Journal of Epidemiology},
year = {2025},
volume = {194},
number = {8},
pages = {2287--2294},
doi = {10.1093/aje/kwae368}
}
EUVIMED